Universal Health Services Inc has a consensus price target of $144.11, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Stephens & Co., and Deutsche Bank on April 26, 2024, April 25, 2024, and April 12, 2024. With an average price target of $192.33 between Barclays, Stephens & Co., and Deutsche Bank, there's an implied 15.82% upside for Universal Health Services Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/26/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 13.81% | Barclays | Andrew Mok | $181 → $189 | Maintains | Equal-Weight | Get Alert |
04/25/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 11.41% | Stephens & Co. | Scott Fidel | → $185 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
04/12/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 22.24% | Deutsche Bank | Pito Chickering | $208 → $203 | Maintains | Buy | Get Alert |
04/10/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | -6.06% | Cantor Fitzgerald | Sarah James | → $156 | Reiterates | Underweight → Underweight | Get Alert |
03/28/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 20.44% | Wells Fargo | Stephen Baxter | $195 → $200 | Maintains | Overweight | Get Alert |
03/13/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 9.6% | JP Morgan | Calvin Sternick | $144 → $182 | Maintains | Neutral | Get Alert |
03/12/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 10.2% | RBC Capital | Ben Hendrix | $161 → $183 | Maintains | Sector Perform | Get Alert |
03/06/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 20.44% | Mizuho | Ann Hynes | $175 → $200 | Maintains | Buy | Get Alert |
03/06/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 9% | Barclays | Andrew Mok | → $181 | Initiates | → Equal-Weight | Get Alert |
03/05/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | -6.06% | Cantor Fitzgerald | Sarah James | → $156 | Reiterates | Underweight → Underweight | Get Alert |
03/04/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 13.81% | Goldman Sachs | Jamie Perse | $170 → $189 | Maintains | Buy | Get Alert |
03/01/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 9% | TD Cowen | Gary Taylor | $140 → $181 | Maintains | Market Perform | Get Alert |
02/29/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | -6.06% | Cantor Fitzgerald | Sarah James | $148 → $156 | Maintains | Underweight | Get Alert |
02/29/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 16.22% | Citigroup | Jason Cassorla | $170 → $193 | Maintains | Buy | Get Alert |
02/29/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 6.59% | UBS | Andrew Mok | $152 → $177 | Maintains | Neutral | Get Alert |
01/02/2024 | UHS | Buy Now | Universal Health Servs | $166.06 | 6.59% | Wells Fargo | Stephen Baxter | → $177 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/11/2023 | UHS | Buy Now | Universal Health Servs | $166.06 | — | Goldman Sachs | Jamie Perse | — | Upgrade | Sell → Buy | Get Alert |
11/17/2023 | UHS | Buy Now | Universal Health Servs | $166.06 | -13.28% | JP Morgan | Calvin Sternick | $152 → $144 | Maintains | Neutral | Get Alert |
10/20/2023 | UHS | Buy Now | Universal Health Servs | $166.06 | -16.3% | Wells Fargo | Stephen Baxter | $153 → $139 | Maintains | Equal-Weight | Get Alert |
The latest price target for Universal Health Servs (NYSE: UHS) was reported by Barclays on April 26, 2024. The analyst firm set a price target for $189.00 expecting UHS to rise to within 12 months (a possible 13.81% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Universal Health Servs (NYSE: UHS) was provided by Barclays, and Universal Health Servs maintained their equal-weight rating.
The last upgrade for Universal Health Services Inc happened on January 2, 2024 when Wells Fargo raised their price target to $177. Wells Fargo previously had an equal-weight for Universal Health Services Inc.
The last downgrade for Universal Health Services Inc happened on March 1, 2023 when Wolfe Research changed their price target from N/A to N/A for Universal Health Services Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on April 26, 2024 so you should expect the next rating to be made available sometime around April 26, 2025.
While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a maintained with a price target of $181.00 to $189.00. The current price Universal Health Servs (UHS) is trading at is $166.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.